Document is current
Any future updates will be listed below
-
Authors
Strube, Wolfgang
Aksar, Aslihan
Bauer, Ingrid
Barbosa, Susana
Benros, Michael
Blankenstein, Christiane
Campana, Mattia
Davidovic, Laetitia
Glaichenhaus, Nicolas
Falkai, Peter
Görlitz, Thomas
Hansbauer, Maximilian
Heilig, Daniel
Khalfallah, Olfa
Leboyer, Marion
Martinuzzi, Emanuela
Mayer, Susanne
Moussiopoulou, Joanna
Papazova, Irina
Perić, Natasa
Wagner, Elias
Schneider-Axmann, Thomas
Simon, Judit
Hasan, Alkomiet
-
Funding
Funding for this research was provided by:
EraPerMed (9088-00002B, 01KU2002, I 4725-B)
Universität Augsburg
- License Information
-
More Information
Article History
Received: 15 September 2022
Accepted: 2 November 2022
First Online: 19 November 2022
Declarations
:
: WS has received a speaker's honorarium from Mag&More GmbH and neurocare and was a member of the advisory board of Recordati. EW was a member of the advisory board of Recordati. PF is a co-editor of the German (DGPPN) Schizophrenia treatment guidelines and a co-author of the WFSBP schizophrenia treatment guidelines. He is on the advisory boards and receives speaker fees from Janssen, Lundbeck, Otsuka, Servier and Richter. AH is co-editor of the German (DGPPN) Schizophrenia treatment guidelines and first-author of the WFSBP schizophrenia treatment guidelines. He has been on the advisory boards and has received speaker fees from Janssen, Lundbeck and Otsuka. All other authors declare no competing financial interests.
